| Literature DB >> 29519717 |
Elisa Rubino1, Ming Zhang2, Tiziana Mongini3, Silvia Boschi4, Liliana Vercelli5, Alessandro Vacca5, Flora Govone5, Annalisa Gai5, Maria Teresa Giordana3, Mark Grinberg2, Ekaterina Rogaeva2, Innocenzo Rainero3.
Abstract
Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM). The aim of the study was to evaluate the prevalence of CHCHD2 and CHCHD10 mutations in Italian MM patients without mitochondrial DNA mutations. The coding regions of CHCHD2 and CHCHD10 were sequenced in 62 MM patients. None of the patients showed CHCHD2 mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in CHCHD10. Muscle biopsy of this patient showed intracellular glycogen accumulation with cytochrome c oxidase negative and ragged red fibers. Our study suggests that the homozygous Pro96Thr mutation in CHCHD10 might be pathogenic but does not support a major role for CHCHD2 in MM pathogenesis. CrownEntities:
Keywords: CHCHD10; CHCHD2; Mitochondrial disease; Mitochondrial myopathy
Mesh:
Substances:
Year: 2018 PMID: 29519717 DOI: 10.1016/j.neurobiolaging.2018.02.007
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673